Pharm Exec Podcast Series:
Bill Trombetta Industry Audit (Part 3)

Continuing Pharm Exec editor Patrick Clinton’s conversation with Bill Trombetta on the top four pharma companies and what makes them special.

Johnson & Johnson: A perennial member of the Top Four, J&J defies the conventional wisdom; it’s a big company that still manages to grow, a sprawling, diversified company that still has focus. And along with just three other companies on our list, it created shareholder value in 2007. Bill Trombetta explains how.